Literature DB >> 18590834

Osteopontin is dispensable for protection against high load systemic fungal infection.

Ikuko Sato1, Nobuchika Yamamoto, Susan R Rittling, David T Denhardt, Motohiro Hino, Junko Morimoro, Fumihiko Sakai, Akihiko Fujie, Toshimitsu Uede.   

Abstract

Osteopontin (OPN) is a multi-functional cytokine which is involved in the pathogenesis of autoimmune disease. We previously reported that thrombin-cleaved form of OPN plays a pathogenic role in murine model of rheumatoid arthritis (RA) by using neutralizing antibody (M5) reacting against the cryptic epitope within OPN, exposed by thrombin cleavage of OPN. It has been shown that OPN-deficient mice are susceptible to various infections, demonstrating the protective role of OPN against various infectious diseases. However, it remains to be clarified whether and how OPN is involved in protection against systemic fungal infection. In a murine model of systemic fungal infection, OPN-deficient mice showed the increase in the susceptibility to low load, but not to high load fungal infection, indicating the protective of OPN against mild or severe forms of infections. However, mice treatment with M5 antibody did not alter the susceptibility to both high and low load fungal infection. These experiments suggest that in sharp contrast to the complete abrogation of OPN expression in OPN-deficient mice, the neutralization of OPN by antibody against thrombin-cleaved form of OPN does not interfere with the host defense against high and low load fungal infection. These findings suggest that the neutralizing antibody which is specific for the epitope of thrombin-cleaved OPN may become an attractive therapeutic means for the treatment of RA without interfering host defense system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590834     DOI: 10.1016/j.intimp.2008.06.001

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

Review 1.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

2.  Myelopoiesis embraces its inner weakness.

Authors:  Motti Gerlic; Ben A Croker
Journal:  Nat Immunol       Date:  2017-08-22       Impact factor: 25.606

3.  Cutting edge: critical role of intracellular osteopontin in antifungal innate immune responses.

Authors:  Makoto Inoue; Yasuhiro Moriwaki; Tomohiro Arikawa; Yu-Hsun Chen; Young Joo Oh; Timothy Oliver; Mari L Shinohara
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.